188 related articles for article (PubMed ID: 28427954)
1. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.
Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA
Am J Prev Med; 2017 Sep; 53(3):335-344. PubMed ID: 28427954
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
[TBL] [Abstract][Full Text] [Related]
3. Determinants of racial/ethnic colorectal cancer screening disparities.
Jerant AF; Fenton JJ; Franks P
Arch Intern Med; 2008 Jun; 168(12):1317-24. PubMed ID: 18574089
[TBL] [Abstract][Full Text] [Related]
4. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
Liss DT; Baker DW
Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
[TBL] [Abstract][Full Text] [Related]
5. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.
Burnett-Hartman AN; Mehta SJ; Zheng Y; Ghai NR; McLerran DF; Chubak J; Quinn VP; Skinner CS; Corley DA; Inadomi JM; Doubeni CA;
Am J Prev Med; 2016 Oct; 51(4):e107-15. PubMed ID: 27050413
[TBL] [Abstract][Full Text] [Related]
6. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
[TBL] [Abstract][Full Text] [Related]
7. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
[TBL] [Abstract][Full Text] [Related]
8. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort.
Podmore C; Selby K; Jensen CD; Zhao WK; Weiss NS; Levin TR; Schottinger J; Doubeni CA; Corley DA
JAMA Netw Open; 2024 Apr; 7(4):e245295. PubMed ID: 38625704
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.
Etzioni DA; Ponce NA; Babey SH; Spencer BA; Brown ER; Ko CY; Chawla N; Breen N; Klabunde CN
Cancer; 2004 Dec; 101(11):2523-32. PubMed ID: 15505783
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial.
Goldman SN; Liss DT; Brown T; Lee JY; Buchanan DR; Balsley K; Cesan A; Weil J; Garrity BH; Baker DW
J Gen Intern Med; 2015 Aug; 30(8):1178-84. PubMed ID: 25814264
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Screening and Race in an Equal Access Medical System.
Haddad JD; You DM
J Community Health; 2016 Feb; 41(1):78-81. PubMed ID: 26187092
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
[TBL] [Abstract][Full Text] [Related]
14. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
15. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening.
Soneji S; Armstrong K; Asch DA
J Oncol Pract; 2012 Sep; 8(5):e125-34. PubMed ID: 23277775
[TBL] [Abstract][Full Text] [Related]
17. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
18. Influence of patient-provider communication on colorectal cancer screening.
Carcaise-Edinboro P; Bradley CJ
Med Care; 2008 Jul; 46(7):738-45. PubMed ID: 18580394
[TBL] [Abstract][Full Text] [Related]
19. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
Gordon NP; Green BB
BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
